Aripiprazole in the treatment of acute manic or mixed episodes in

Download Report

Transcript Aripiprazole in the treatment of acute manic or mixed episodes in

Aripiprazole in the
treatment of acute manic
or mixed episodes in
patients with bipolar I
disorder:
• Dosing could be reduced to 15
mg/day for Tolerability
• Aripiprazole : no significant
difference from placebo in change in
mean body weight
• not associated with elevated
prolactin or QTc prolongation
• fasting glucose,
• fasting insulin
• insulin
resistance index
• cholesterol
• triglycerides
• low-density
lipoprotein (LDL)
• LDL/HDL,
• Chol/HDL
treatment of an acute manic
episode for up to 12 weeks
Aripiprazole showed superior
levels of response and
tolerability to haloperidol
• Aripiprazole showed similar
efficacy to olanzapine for longterm treatment of acutely
psychotic and chronic, stable
schizophrenia patients,
• lower liability for weight gain or
increased lipid levels
Aripiprazole: initial clinical experience with 142
hospitalized psychiatric patients.
• daily dose, 16.1 +/- 6.2 mg
• body weight: 0.20 +/- 0.09 mg/kg
• aripiprazole is likely to be onsidered
for obese patients
• weight should be considered
short-term treatment of
schizophrenia
1. aripiprazole 15-30 mg is
as effective
2. haloperidol 10 mg/day
3. risperidone 6 mg/day
Aripiprazole
• quinolinone derivative
• high affinity for D2 , D3 receptors
• partial agonist action on 5-HT (1A)
receptors
• 5-HT (2A) receptors antagonist
• active metabolite: dehydroaripiprazole, = parent compound
dopamine D2 receptors
• peak plasma concentration=3 hours
• Steady-state plasma concentrations
are achieved by 14 days
• CYP3A4 and CYP2D6 transform it to
dehydroaripiprazole
• genetic polymorphism
• The drug is effective as early as the
first or second week of treatment.
• No additional therapeutic benefit
at the higher-than-recommended
dosages
induce weight gain
•
•
•
•
clozapine and olanzapine.
TCA, mirtazapine come next
majority of the mood stabilizers.
The old antipsychotics seem to
involve less gain of weight.
• SSRI make lose weight in the first
weeks, but induce a moderate
weight gain on the long term.